2026 Biomedical Final Pitch Competition and Conference
5 月 23 日及 24 日
报名截止日期：5 月 19 日
联合主办方：
Boston Capital Investment Club (BCIC)
Hong Kong Science and Technology Parks Corporation (HKSTP)
诚邀您参加 2026 Biomedical Pitch Competition Final Pitch Event，搭建生物医疗初创企业与投资人及商业加速资源之间的桥梁。来自早期至中期阶段、覆盖制药、医疗器械与诊断领域的 17 支 Finalist 团队及 4 支 pitch-only 精选团队将公开展示他们的项目。
精彩看点：
- 高层次观众群： 200+ Angel/VC 基金及行业领袖到场，寻找具有突破性的生物医疗解决方案。
- 多元合作机会： 探索潜在直接投资、licensing partnerships 及具有价值的战略合作。
- 媒体曝光度： 借助覆盖 20,000+ 受众的媒体报道获得广泛关注。
深远影响：近年成功案例
- Leveragen，2024 届创赛获奖团队，已于 2026 年 3 月宣布与 Daiichi Sankyo 达成战略合作
- 2025 届一支获奖团队于 2026 年 1 月完成 NewCo spin-off 交易
- 2023 届一支获奖团队于 2025 年底成功获得后续融资（follow-on funding）
- Innovative Cellular Therapeutics (ICT)，2025 届获奖团队之一，于 2025 年 11 月将 LYL273 (GCC19CART) 的全球权益出让给 Lyell Immunopharma
2025 Pitch Competition 精选成果 Epigenic 成功融资 6,000 万美元（Affinity Secures Funding） Groovy 完成融资（Groovy Secured Funding） 2026 年 1 月达成 NewCo 交易一例 Innovative Cellular Therapeutics (ICT) 于 2025 年 11 月达成 BD deal（ICT Sells Global Rights）
2024 Pitch Competition 精选成果 Rapafusyn 在美国成功融资 4,400 万美元（BCIC Ecosystem｜创赛获奖Rapafusyn融资4400万美元） Agilis 自一家新加坡 family office 成功获得 1,000 万美元投资（Agilis Raised $10M） GV20 成功获得超过 3,000 万美元融资（GV20 Therapeutics Secured Funding over $30 Million） Affinity 完成 5,500 万美元融资（Affinity Secures Funding） ImmViral 提交 IPO 申请（ImmViral Files for IPO） Leveragen 于 2026 年宣布与 Daiichi Sankyo 达成合作**（Leveragen BD Deal）**
2023 Pitch Competition 精选成果 Myrobalan 在参加 pitch competition 后 5 个月内于美国成功融资 2,400 万美元（Myrobalan Therapeutics secures funding of $24 Million） 两支初创公司分别完成 200 万美元融资。 至少有一支初创团队在亚洲落地。 一家公司于 2025 年底获得 follow-on funding。
2022 Pitch Competition 精选成果 Amytrx 已融资 1,800 万美元 ARIZ Precision Medicine 已融资 300 万美元 Biostage 已融资 500 万美元 至少两家初创公司在亚洲落地
日期：
Day 1 — Final Pitch Day
5 月 23 日（星期六）8:30am – 5:30pm
Day 2 — Morning Conference
5 月 24 日（星期日）9:00am – 12:30
地点：现场参会需持票入场
Fish & Richardson P.C 会议厅（17 楼）
1 Marina Park Drive, Boston, MA 02210
议程：
参会形式：
In-Person（现场出席）： 名额有限，仅向受邀嘉宾及购票观众开放。
Virtual（线上参会）： 面向所有完成在线注册的观众开放。
报名截止日期：5 月 19 日
请扫描下方二维码完成报名
https://bcic.ticketspice.com/2026-biomedical-final-pitch-and-conference
如有任何问题，请发送邮件至：info@bcicglobal.org
联合主办方与赞助商
Boston Capital Investment Club (BCIC) — The Boston Capital Investment Club (BCIC) is a Massachusetts-registered non-profit organization serving nearly 10,000 professionals in finance, venture capital, and various technology industries. Beyond being a Boston-centered platform, the BCIC has grown to facilitate nationwide and international knowledge exchange across healthcare, finance, and related fields. Since 2022, the organization has hosted annual biomedical pitch competitions, empowering startups to secure over $300 million in collective funding.
Hong Kong Science and Technology Parks Corporation (HKSTP) — With a 20-year history of transforming lives through innovation, technology and entrepreneurship, HKSTP has been propelling success for the most creative minds and innovators around the globe, accelerating ambitions and delivering positive impact from Hong Kong to the Greater Bay Area and the world. https://www.hkstp.org/
Fish & Richardson P.C. — As the leading IP law firm, we help innovators change the world through our unmatched litigation, prosecution, and post-grant experience. Many of our 450+ attorneys and technology specialists are also scientists who are as comfortable in a lab or cleanroom as a courtroom or patent office.
Shanghai InnoStar — Shanghai InnoStar Bio-tech Co., Ltd. (InnoStar) was established in 2010. As a leading contract research organization, InnoStar has passed GLP inspections by US FDA and received GLP certification from NMPA, OECD, AAALAC, and CAP. Business scope covers screening and discovery, nonclinical pharmacodynamics, pharmacokinetics, safety evaluation, clinical sample bioanalysis, biomarkers and translational research. Listed on the STAR Market of Shanghai Stock Exchange (Stock code: 688710).
Porton Pharma Solutions Ltd — Founded in 2005, Porton is an internationally recognized pharmaceutical CDMO enabling global clients to optimize drug development and manufacturing across Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, RDCs), and Advanced Therapy Medicinal Products from pre-clinical to commercialization stages.
PanaCRO — A full-service clinical CRO founded in 2004, helping global biotech and biopharma companies accelerate clinical development in China. With 500+ employees, coverage across 20+ provinces, collaboration with 800+ research sites, PanaCRO provides end-to-end solutions from pre-IND/IND strategy and regulatory support to IITs, Phase I–III studies, NDA/BLA registration, and post-market real-world studies, combining deep local regulatory knowledge with international ICH-GCP standards.
Simcere Pharmaceutical Group — An innovation and R&D-driven pharmaceutical company focused on oncology, nervous system, autoimmune and antiinfection therapeutic areas, with the corporate mission of "providing today's patients with medicines of the future". Simcere has established several R&D innovation centers around the world, including the Boston Innovation Center in Cambridge.
Fenwick — A top law firm serving technology and life sciences clients with 500+ attorneys, nationally recognized for complex transactions, IP protection, M&A, and tax. Landmark work includes incorporating Apple, taking Oracle, eBay, and 180+ others public, and defending key biotech patents.
Final Pitch 评委（Judges）
- Hong Kong Science and Technology Parks Corporation (HKSTP)
- Northern Light Venture Capital (NLVC)
- TCG Crossover
- RA Capital
- Chugai Venture
- Kendall Capital Partners
- PagodaTree Partners
- Eisai Innovation, Inc
- HM Capital
媒体合作伙伴（Media Partners）
- Deep Blue
- SaiBaiLan
- E Drug
- Drug Times
- Gene Online
- Page Executive
- BoYao
- VC Beat
特别鸣谢以下机构对本次活动的推广支持
· Harvard Life Lab · Harvard Innovation Labs · Harvard Wyss Institute · Harvard Medical School CSSA · Ohio State University College of Pharmacy Innovation Center · Pittsburg University Healthcare Incubator · Stanford University Healthcare Innovation Lab – Stanford Pipeline · Nest.Bio · Netherlands Innovation Center (NIC) · Frees Fund · JJLake Asia Future Innovation Challenger · Dane Capital · Aquillius · Simcere Therapeutical · Blue Ocean Capital Group · Chinese Entrepreneurs Organization at Duke (DukeCEO) · Penn Quakers Venture Club · Fish & Richardson · InnoStar · Porton · 闻药事
· Yale Venture Club · The Hopkins Club for Innovation and Entrepreneurship · Asia America Innovation Alliance (AAIA) · GeneOnline · Life-Science Entrepreneurship and Plus (LEAP) · Huazhong University of Science and Technology (HUST) Boston Alumni Association · Tongji Medical College of HUST Boston Chapter · YuanBio Venture Capital · AAEA · PagodaTree Partners · AbbVie Ventures · F Prime · Amgen Venture · TOP Innovation Districts Lab · Greenberg Traurig · Baker Mckenzie · The Chinese Antibody Society (CAS) – Berkley QB3 – Startup Boston · 博药 · 前途汇 · Biolink
· VIVA · Medicilon · ATLATL · Xingu Chuangfu · Alliance of Venture and Entrepreneurs Organization for Chinese Students Alumni at Harvard · Slush China · Danen Capital · Association d'Incubateur Franco-Chinois (AIFC) · Brandeis Impact · Chinese Entrepreneurs Organization · CuBio Innovation Center · HiMed · HuaSu Future · Eisai Innovation Inc · Regent Advisors · Enterprise Singapore · Massachusetts Biomedical Initiatives (MBI) · K2 Venture Partners · Singapore Economic Development Board (EDB) · Saudi Aribia NEOM Biotech Investment · P4 Precision Medicine Accelerator (UK)
17+4 Finalists 与 Roadshow-only 团队
